🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/09/1997 | 61,29 | 62,23 | 61,06 | 61,76 | +0,00% | 1,91% | 31.953 |
| 29/09/1997 | 61,53 | 63,16 | 59,89 | 61,76 | +1,54% | 5,32% | 111.596 |
| 26/09/1997 | 63,63 | 63,63 | 59,89 | 60,82 | -4,06% | 5,88% | 89.848 |
| 25/09/1997 | 63,16 | 66,44 | 62,69 | 63,40 | +3,44% | 5,93% | 115.843 |
| 24/09/1997 | 62,23 | 62,23 | 61,29 | 61,29 | +0,00% | 1,50% | 23.297 |
| 23/09/1997 | 64,10 | 64,10 | 61,29 | 61,29 | -3,68% | 4,38% | 36.094 |
| 22/09/1997 | 63,63 | 64,33 | 62,93 | 63,63 | +0,37% | 2,21% | 70.185 |
| 19/09/1997 | 63,40 | 63,63 | 63,16 | 63,40 | +0,00% | 0,74% | 35.213 |
| 18/09/1997 | 63,16 | 63,63 | 61,76 | 63,40 | +0,74% | 2,96% | 206.360 |
| 17/09/1997 | 60,36 | 62,93 | 60,36 | 62,93 | +3,46% | 4,26% | 70.692 |
| 16/09/1997 | 62,69 | 62,93 | 59,89 | 60,82 | -1,52% | 4,85% | 113.332 |
| 15/09/1997 | 62,69 | 63,63 | 61,29 | 61,76 | -0,75% | 3,73% | 100.936 |
| 12/09/1997 | 59,89 | 62,23 | 59,89 | 62,23 | +3,50% | 3,91% | 137.644 |
| 11/09/1997 | 60,36 | 60,36 | 59,42 | 60,12 | +0,39% | 1,55% | 90.089 |
| 10/09/1997 | 59,89 | 60,59 | 59,89 | 59,89 | +0,00% | 1,17% | 171.548 |
| 09/09/1997 | 59,89 | 59,89 | 59,42 | 59,89 | +0,00% | 0,78% | 147.316 |
| 08/09/1997 | 59,89 | 59,89 | 59,42 | 59,89 | +0,39% | 0,78% | 92.413 |
| 05/09/1997 | 60,36 | 60,36 | 59,19 | 59,65 | -1,16% | 1,94% | 109.485 |
| 04/09/1997 | 58,48 | 61,29 | 58,48 | 60,36 | +3,61% | 4,80% | 300.055 |
| 03/09/1997 | 57,55 | 58,95 | 56,61 | 58,25 | +2,89% | 4,07% | 184.906 |
| 02/09/1997 | 55,68 | 57,08 | 55,21 | 56,61 | +4,31% | 3,36% | 126.263 |
| 29/08/1997 | 53,81 | 54,27 | 53,34 | 54,27 | +0,87% | 1,74% | 35.026 |
| 28/08/1997 | 54,74 | 55,21 | 53,34 | 53,81 | -2,54% | 3,42% | 93.909 |
| 27/08/1997 | 57,55 | 58,02 | 52,87 | 55,21 | +7,27% | 8,94% | 248.251 |
| 26/08/1997 | 49,13 | 53,10 | 49,13 | 51,47 | +1,85% | 8,10% | 159.979 |
| 25/08/1997 | 46,79 | 50,53 | 46,32 | 50,53 | +8,00% | 9,00% | 86.135 |
| 22/08/1997 | 46,32 | 47,02 | 44,92 | 46,79 | +0,00% | 4,55% | 46.327 |
| 21/08/1997 | 45,15 | 47,26 | 44,92 | 46,79 | +4,17% | 5,18% | 55.865 |
| 20/08/1997 | 44,45 | 45,15 | 43,98 | 44,92 | +0,52% | 2,63% | 66.204 |
| 19/08/1997 | 44,92 | 45,38 | 44,45 | 44,68 | -0,52% | 2,08% | 38.151 |